论文部分内容阅读
“6911”是中国科学院植物研究所、北京制药厂协作试制成功的新药。我厂向北京学习的基础上,试制成功6911片,产品经鉴定符合国家规定的质量标准,并曾于浙江省中医院等六个医疗单位临床,用于心血管和脑血管疾患,疗效普遍反映良好。据浙江省中医院心血管病防治小组的临床疗效统计,用于治疗“冠心”心绞痛方面总有效率为92.39%,其中显效为
“6911 ” is a new drug successfully researched and manufactured by Institute of Botany, Chinese Academy of Sciences and Beijing Pharmaceutical Factory. Based on the study of our factory in Beijing, 6911 tablets were successfully trial-produced. The products were certified to meet the quality standards stipulated by the state. They were used clinically in six medical units such as Zhejiang Provincial Hospital of Traditional Chinese Medicine for cardiovascular and cerebrovascular diseases, and their therapeutic effects are generally reflected good. According to the Zhejiang Provincial Hospital of cardiovascular disease prevention and control group clinical efficacy statistics, for the treatment of “coronary heart” angina total effective rate was 92.39%, of which markedly effective